Rchr
J-GLOBAL ID：201401074851669410
Update date: Jan. 20, 2025
Ito Tatsuya
イトウ タツヤ | Ito Tatsuya
Affiliation and department：
Research field (1)：
Medical equipment testing
Research theme for competitive and other funds (5)：
- 2024 - 2025 薬局で実施可能な簡便で効果的な減酒支援プログラムの開発と効果の検証
- 2021 - 2024 Regulatory Systems and Education Environment for Promoting Research Integrity
- 2017 - 2021 Establishing a governance system for residual biospecimens and health information based on trust through value sharing with the public
- 2017 - 2021 Legislation comparison of research integrity in Europe and development of research integrity in Japan
- 2009 - 2011 スーパー特区における臨床試験の基盤形成と完遂を促進する教育プログラムの開発研究-アカデミアにおけるスポンサー機能の充実をめざして-
Papers (29)：
-
Kambe N., Yamamoto M., Takemura K., Kagami S., Kawahara Y., Yoshifuji H., Jo T., Izawa K., Nakamizo S., Inoue N., et al. Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome. Allergology International. 2024
-
Hidehiro Someko, Norio Yamamoto, Tatsuya Ito, Tomoharu Suzuki, Takahiro Tsuge, Hajime Yabuzaki, Eisuke Dohi, Yuki Kataoka. Misleading presentations in functional food trials led by contract research organizations were frequently observed in Japan: meta-epidemiological study. Journal of Clinical Epidemiology. 2024. 169. 111302-111302
-
Hiroki Yamanaka, Eiichi Sawaragi, Takashi Nakano, Yasuhiro Katayama, Tatsuya Ito, Harue Tada, Yu Hidaka, Satoshi Morita, Chihiro Funakoshi, Akemi Kinoshita, et al. A high-hydrostatic pressure device for nevus tissue inactivation and dermal regeneration for reconstructing skin defects after giant congenital melanocytic nevus excision: a clinical trial. Regenerative Therapy. 2023. 24. 167-173
-
Ryosuke Kurauchi, Hiroi Kasai, Tatsuya Ito. Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports. Frontiers in Bioengineering and Biotechnology. 2020. 8
-
Lara Bernasconi, Selçuk Şen, Luca Angerame, Apolo P. Balyegisawa, Damien Hong Yew Hui, Maximilian Hotter, Chung Y. Hsu, Tatsuya Ito, Francisca Jörger, Wolfgang Krassnitzer, et al. Legal and ethical framework for global health information and biospecimen exchange - an international perspective. BMC Medical Ethics. 2020. 21. 1
ｍore...
MISC (21)：
-
伊藤 達也, 池田浩治, 菅原岳史, 伊師賢樹, 山地学, 植田康平, 岡田潔, 名井陽. 橋渡し支援拠点間連携としてのARO薬事専門家連絡会の活動. 第1回RSのあり方研究会. 2017
-
伊藤 達也. アカデミアにおける臨床開発支援 ~希少疾病薬レプチンの開発~. 第31回日本薬剤学会学術大会. 2016
-
Tatsuya Ito. Differences of characteristics in investigator-initiated trials between Japan and other countries. 28th DIA Annual EuroMeeting. 2016
-
Tatsuya Ito, Gillian Tallents, Liam McKervey, Rachel Davies, Jessica Bisset, Jake Harley, Diana Benton, Birgit Whitman. Comparison of the research governance frameworks for research involving humans, their tissue and/or data in the UK and Japan. 27th DIA Annual EuroMeeting. 2015
-
N. Morimoto, K. Yoshimura, M. Niimi, T. Ito, R. Aya, J. Fujitaka, H. Tada, S. Teramukai, T. Murayama, C. Toyooka, et al. Tissue Engineering (vol 19, pg 1931, 2013). TISSUE ENGINEERING PART A. 2014. 20. 13-14. 2030-2030
ｍore...
Lectures and oral presentations (14)：
-
オープンデータを用いたベンゾジアゼピン系薬物の使用状況及び有害事象発生状況の調査
(第2回和歌山県立医科大学薬学部学術交流集会 2024)
-
Analysis of age-tre;in self-medication utilizing the population by age;pharmaceutical sales
(Programme of the 43rd Annual Meeting of Japanese Classification Society)
-
橋渡し研究支援機関でのPMDA RS戦略相談対応支援における効果的なプロジェクトマネジメント
(第22回日本再生医療学会総会 2023)
-
AI医療機器の国内外における動向
(日本臨床試験学会第13回学術集会総会 2022)
-
AROにおけるFIH試験までの非臨床安全性試験計画立案とPMDA相談
(日本臨床試験学会第13回学術集会総会 2022)
ｍore...
Professional career (1)：
Work history (5)：
- 2023/04 - 現在 Wakayama Medical University School of Pharmaceutical Sciences Professor
- 2020/04 - 2023/03 Kyoto University
- 2016/10 - 2020/03 Kyoto University
- 2013/04 - 2015/09 Kyoto University
- 2007/01 - 2013/03 Kyoto University
Return to Previous Page
